{
  "symbol": "MDCX",
  "company_name": "Medicus Pharma Ltd",
  "ir_website": "https://medicuspharma.com/investor-relations/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "2024 Q1 Results",
          "url": "https://medicuspharma.com/investor-relations/press-releases/2024-q1-results",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n# No Results Found\n\nThe page you requested could not be found. Try refining your search, or use the navigation above to locate the post.\n\nSearch\n\nSearch\n\n## Recent Posts\n\n  * [Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer](https://medicuspharma.com/medicus-pharma-ltd-appoints-faisal-mehmud-md-mrcp-as-chief-medical-officer/)\n  * [Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-closing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-pricing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing](https://medicuspharma.com/medicus-pharma-ltd-announces-share-consolidation-in-anticipation-of-proposed-u-s-listing/)\n  * [Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults](https://medicuspharma.com/medicus-pharma-ltd-announces-first-patient-randomized-in-phase-2-trial-of-sknjct-003-for-the-treatment-of-nodular-basal-cell-carcinoma-in-adults/)\n\n\n\n## Recent Comments\n\nNo comments to show.\n"
        },
        {
          "title": "2024 Annual Shareholder Meeting",
          "url": "https://medicuspharma.com/investor-relations/press-releases/2024-annual-shareholder-meeting",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n# No Results Found\n\nThe page you requested could not be found. Try refining your search, or use the navigation above to locate the post.\n\nSearch\n\nSearch\n\n## Recent Posts\n\n  * [Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer](https://medicuspharma.com/medicus-pharma-ltd-appoints-faisal-mehmud-md-mrcp-as-chief-medical-officer/)\n  * [Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-closing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-pricing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing](https://medicuspharma.com/medicus-pharma-ltd-announces-share-consolidation-in-anticipation-of-proposed-u-s-listing/)\n  * [Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults](https://medicuspharma.com/medicus-pharma-ltd-announces-first-patient-randomized-in-phase-2-trial-of-sknjct-003-for-the-treatment-of-nodular-basal-cell-carcinoma-in-adults/)\n\n\n\n## Recent Comments\n\nNo comments to show.\n"
        }
      ]
    },
    {
      "section_name": "Email Alerts",
      "links": [
        {
          "title": "Sign up for email alerts",
          "url": "https://medicuspharma.com/investor-relations/email-alerts/",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\nEmail Alerts\n\n#### Investor Relations\n\n  * [Overview](https://medicuspharma.com/investor-relations/)\n  * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n  * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n  * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n  * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n  * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n  * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n\n\n\n# Email Alerts\n\nPlease fill out the form below to receive company press releases via email when they occur.\n\nWe respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.\n"
        }
      ]
    },
    {
      "section_name": "Corporate Governance",
      "links": [
        {
          "title": "Corporate Governance Policies",
          "url": "https://medicuspharma.com/corporate-govenance/",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\nCorporate Govenance\n\n#### Investor Relations\n\n  * [Overview](https://medicuspharma.com/investor-relations/)\n  * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n  * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n  * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n  * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n  * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n  * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n\n\n\n# Governance Documents\n"
        }
      ]
    }
  ]
}